The p53-caspase-2 axis in the cell cycle and DNA damage response

Y Lim, L Dorstyn, S Kumar - Experimental & Molecular Medicine, 2021 - nature.com
Caspase-2 was discovered almost three decades ago. It was one of the first two mammalian
homologs of CED-3, the other being interleukin 1β-converting enzyme (ICE/caspase-1) …

Caspases in metabolic disease and their therapeutic potential

CH Wilson, S Kumar - Cell Death & Differentiation, 2018 - nature.com
Caspases, a family of cysteine-dependent aspartate-specific proteases, are central to the
maintenance of cellular and organismal homoeostasis by functioning as key mediators of …

Biomarker-based assessment of sublethal toxicity of organic UV filters (ensulizole and octocrylene) in a sentinel marine bivalve Mytilus edulis

H Falfushynska, EP Sokolov, K Fisch, H Gazie… - Science of The Total …, 2021 - Elsevier
The global occurrence of organic UV filters in the marine environment is of increasing
ecotoxicological concern. Here we assessed the toxicity of UV filters ensulizole and …

Caspase-2 as a master regulator of genomic stability

GS Kopeina, B Zhivotovsky - Trends in Cell Biology, 2021 - cell.com
Genomic instability underlies genesis and the development of various types of cancer.
During tumorigenesis, cancer initiating cells assume a set of features, which allow them to …

Caspases orchestrate microglia instrumental functions

X Shen, JL Venero, B Joseph, MA Burguillos - Progress in neurobiology, 2018 - Elsevier
Microglia, the resident immune cells of the brain, can acquire various cell phenotypes based
on their location and current role. This level of plasticity is required to fulfil the vast variety of …

Melittin induces NSCLC apoptosis via inhibition of miR-183

D Gao, J Zhang, L Bai, F Li, Y Dong… - OncoTargets and therapy, 2018 - Taylor & Francis
Background Non-small-cell lung cancer (NSCLC) has one of the highest mortality rates
among cancers worldwide, with a poor prognosis. Previous studies have reported that …

Structure-based design and biological evaluation of novel caspase-2 inhibitors based on the peptide AcVDVAD-CHO and the caspase-2-mediated tau cleavage …

M Bresinsky, JM Strasser, B Vallaster… - ACS Pharmacology & …, 2022 - ACS Publications
Alzheimer's disease (AD) was first described by Alois Alzheimer over 100 years ago, but
there is still no overarching theory that can explain its cause in detail. There are also no …

Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells

M Poreba, W Rut, K Groborz, SJ Snipas… - Cell Death & …, 2019 - nature.com
Most caspases can be positioned unambiguously within the regulated cell death networks of
apoptosis and pyroptosis, but the role of caspase-2, a highly conserved protease within the …

Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics

E Bosc, J Anastasie, F Soualmia, P Coric, JY Kim… - Cell Death & …, 2022 - nature.com
Abstract Caspase-2 (Casp2) is a promising therapeutic target in several human diseases,
including nonalcoholic steatohepatitis (NASH) and Alzheimer's disease (AD). However, the …

Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias

S Pockes, MA Walters, KH Ashe - Translational Research, 2023 - Elsevier
Targeting amyloid-β plaques and tau tangles has failed to provide effective treatments for
Alzheimer's disease and related dementias (ADRD). A more fruitful pathway to ADRD …